Business Wire

Spinnaker Support Delivers Global Double-Digit Growth Fueled by Enterprise Scrutiny of Traditional Vendor Relationships

4.6.2025 16:00:00 EEST | Business Wire | Press release

Share

Spinnaker Support (Spinnaker), the third-party software support leader entrusted by 1,000+ global clients, today announced that the growing market for reliable, trustworthy and strategic global third-party support has fueled double-digit growth across its business. Spinnaker’s support for enterprise SAP, Oracle and VMWare deployments is giving the C-suite valuable breathing room, by avoiding costly vendor lock-in, to make digital transformation decisions to their own timescales, while also securely maintaining legacy systems.

Notable recent client wins include BT (Oracle), Telefónica Germany (Oracle/VMware), Madrileña Gas (SAP), Specsavers (Oracle), Bombardier Recreational Products (SAP) and Abercrombie & Fitch (Oracle). Spinnaker’s key verticals include manufacturing, utilities, telecommunications, financial services, and banking.

Spinnaker’s Oracle support reaches new heights

Spinnaker’s Oracle support continues to grow globally. In March 2025, Spinnaker announced it will be providing support for major telco BT Group’s on-premise Oracle applications in use across the Group’s technology estate. The engagement spans a wide range of critical Oracle applications and sees Spinnaker providing escalated support on key databases and applications within BT Group.

In addition, Spinnaker has also signed Specsavers, Telefónica Germany, and Abercrombie & Fitch for multi-year support contracts.

Alternative option for SAP customers being pushed towards RISE

On the SAP side of its business, Spinnaker provides organizations with an alternative support option as SAP continues to push customers towards RISE.

In February 2025, Spinnaker announced that BRP, a global leader in the world of powersports products, propulsion systems and boats, has selected Spinnaker to provide third-party software support across its SAP applications and technologies. The five-year deal with Spinnaker gives BRP dedicated third-party software support to ensure that SAP Applications and Tech with Global Tax & Regulatory Compliance are maintained across the company’s operations in 22 countries.

In EMEA, Madrileña Red de Gas, one of Spain’s key utility companies, has freed up investment for innovation projects across the organization by outsourcing its entire SAP maintenance support to Spinnaker. With a desire to maintain its current SAP environment but with SAP maintenance costs rising.

The last 12 months has also seen Spinnaker expand its service offering in a number of ways:

Spinnaker launched its VMware support offering after listening to customer concerns following Broadcom’s VMware acquisition

In July 2024, Spinnaker launched its VMware support option, in response to market demand for innovative, up-to-date and flexible support offerings. Interest remains high as VMWare customers reject being forced to switch from a perpetual license model to a costly subscription alternative. Advantages of switching to Spinnaker’s VMware offering include the avoidance of forced subscription models, maintaining security and compliance requirements.

In less than 12 months, Spinnaker’s new VMware division has contracted multiple new customers including Telefónica Germany, Quebec Airport and Specsavers.

Spinnaker Cloud Managed Services launched: empowering organizations to modernize on their own terms

In March 2025, Spinnaker launched Spinnaker Cloud Managed Services - a new offering that allows an organization to actualize its cloud strategy without having to move away from the legacy system(s) their business is built upon. Spinnaker Cloud Managed Services supports Oracle and SAP, environments across both legacy and cloud platforms, delivering a high-touch service with expert management.

Partnerships: Channel vendors embrace Spinnaker’s offering

As Oracle, SAP and VMware customers are being pushed to subscription licensing consultancy, software and licensing partner companies are including Spinnaker Third-Party Software Support to enhance their offerings. New partners include Avanade, SoftwareOne, Preo-Soft, 2Data, joining IBM, Prolicense and other global vendors to enable their customers to take control of their digital future.

Security: As security and audit compliance continue to lead to CIO concerns, Spinnaker Shield’s holistic approach ensures stability.

As the digital world is increasingly under attack from cyber threats, this is causing companies to close ranks and keep their data on-premise, or at the very least hosted in their home country. This is at odds with the major software vendors driving applications onto their cloud platforms. Spinnaker can keep its customers’ data secure and optimized on-site and avoid risky migrations and unknown threats.

Matt Stava, CEO of Spinnaker Support said: “The market for third-party software support is growing fast and so is Spinnaker Support. We have seen global brands make the jump and entrust Spinnaker Support with their on-going software support needs. Our personal, consultative and experienced global experts give enterprises the ability and time to move at their own pace, not that of the software vendors support offerings, while realizing significant cost benefits as they decide on their future digital strategies.”

Spinnaker offers ‘The Ultimate Support Guarantee’, an industry-first agreement designed to mitigate any perceived risks associated with switching away from Oracle, SAP or VMware support.

For more information about Spinnaker Support, visit www.spinnakersupport.com.

About Spinnaker Support

Spinnaker Support delivers global, independent third-party software support for Oracle, SAP, and VMware, along with managed services and cloud solutions for Oracle and SAP. Trusted by companies worldwide, including those in highly regulated industries, Spinnaker empowers organizations to take control of their IT strategy. By breaking free from vendor-imposed roadmaps, aligning software management with business objectives, reducing costs, and maximizing ROI, Spinnaker provides customers with the power of choice. With a strategic approach to security, performance, resource allocation, and managed services, Spinnaker Support ensures long-term IT efficiency and success.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250604389607/en/

Contacts

Spinnaker Support press contact:
Dan Walsh
MUSTARD PR
dan@mustardpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye